Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients
Yutaro Ohki(Jikei University School of Medicine), Takashi Yokoo(Jikei University School of Medicine), Mayuko Kawabe(Jikei University School of Medicine), Nanae Matsuo(Jikei University School of Medicine), Yudo Tanno(Jikei University School of Medicine), Jun Miki(Jikei University School of Medicine), Ichiro Ohkido(Jikei University School of Medicine), Haruki Katsumata(Jikei University School of Medicine), Yasuyuki Nakada(Jikei University School of Medicine), Tetsuya Horino(Jikei University School of Medicine), Hiroyasu Yamamoto(Japanese Society for Dialysis Therapy), Hiroki Yamada(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Akimitsu Kobayashi(Jikei University School of Medicine), Izumi Yamamoto(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine)
Cited by 8
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes
|Annals of the Rheumatic Diseases|2016|177
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
|Experimental & Molecular Medicine|2019|112